Related Experiment Video
Updated: Jun 14, 2026
05:33
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation
Journal of Medicinal Chemistry
|June 12, 2026
Summary
This study introduces self-assembled nanoparticles from amphiphilic Proteolysis-targeting chimeras (PROTACs) to overcome limitations in targeted protein degradation therapies. These PROTAC nanoparticles show improved efficacy and reduced toxicity for cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Proteolysis-targeting chimeras (PROTACs) offer targeted protein degradation but face clinical challenges like poor bioavailability and efficacy.
- Existing PROTAC formulations often suffer from high molecular weight and low cellular permeability, hindering therapeutic application.
Purpose of the Study:
- To develop a self-assembled nanoparticle system (PRO NPs) from amphiphilic PROTACs to enhance targeted protein degradation therapy.
- To evaluate the improved physicochemical properties, cellular efficacy, and in vivo antitumor activity of PRO NPs compared to free PROTACs.
Main Methods:
- Fabrication of self-assembled nanoparticles (PRO NPs) using amphiphilic PROTACs without external excipients.
- Assessment of aqueous solubility, cellular EGFR degradation in HCC827 cells, and in vivo antitumor efficacy of PRO NPs.
- Functionalization of PRO NPs with hyaluronic acid (HA) for CD44-mediated active tumor targeting.
Main Results:
- PRO NPs demonstrated enhanced aqueous solubility and superior EGFR degradation in HCC827 cells compared to free PROTAC.
- In vivo studies showed PRO NPs actively accumulated at tumor sites, achieving significant tumor growth inhibition (76.8%).
- Hyaluronic acid functionalization and CD44-mediated targeting led to potent antitumor efficacy with reduced systemic toxicity.
Conclusions:
- Self-assembled PRO NPs offer a simplified fabrication process and overcome limitations of conventional PROTACs.
- This nano-PROTAC strategy presents a promising approach for developing effective and safer targeted protein degradation therapies.
- The findings provide valuable insights into designing advanced nano-delivery systems for protein degradation therapeutics.
More Related Videos
10:01Directed Assembly of Elastin-like Proteins into defined Supramolecular Structures and Cargo Encapsulation In Vitro
Published on: April 8, 2020
07:22The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
Published on: January 12, 2024
Related Concept Videos
01:45Tail-anchoring of Proteins in the ER Membrane
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
02:58Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...